title: Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy.
authors.affiliation: Department of Ophthalmology, University of Rome Tor Vergata, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Ricci
authors.affiliation: Department of Ophthalmology, Fondazione G.B.Bietti-IRCCS, Rome, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Parravano
authors.affiliation: Department of Ophthalmology, University of Rome Tor Vergata, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Regine
authors.affiliation: Department of Ophthalmology, Fondazione G.B.Bietti-IRCCS, Rome, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Sciamanna
authors.affiliation: Department of Ophthalmology, Fondazione G.B.Bietti-IRCCS, Rome, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Tedeschi
authors.affiliation: Department of Ophthalmology, University of Rome Tor Vergata, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Missiroli
authors.affiliation: Department of Ophthalmology, Fondazione G.B.Bietti-IRCCS, Rome, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Varano
mesh_terms: D006801:Humans; D040262:Receptors, Vascular Endothelial Growth Factor; D011993:Recombinant Fusion Proteins; D057135:Wet Macular Degeneration
chemical_list: D011993:Recombinant Fusion Proteins; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor